Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Asset Writedowns and Impairment: 2020-2025

Historic Asset Writedowns and Impairment for Zai Lab (ZLAB) over the last 6 years, with Sep 2025 value amounting to $625,000.

  • Zai Lab's Asset Writedowns and Impairment rose 977.59% to $625,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $920,000, marking a year-over-year decrease of 11.62%. This contributed to the annual value of $815,000 for FY2024, which is 16.24% down from last year.
  • As of Q3 2025, Zai Lab's Asset Writedowns and Impairment stood at $625,000, which was up 134.08% from $267,000 recorded in Q2 2025.
  • Over the past 5 years, Zai Lab's Asset Writedowns and Impairment peaked at $966,000 during Q4 2021, and registered a low of -$3,000 during Q4 2022.
  • In the last 3 years, Zai Lab's Asset Writedowns and Impairment had a median value of $227,000 in 2023 and averaged $246,091.
  • Per our database at Business Quant, Zai Lab's Asset Writedowns and Impairment tumbled by 100.31% in 2022 and then spiked by 7,666.67% in 2023.
  • Zai Lab's Asset Writedowns and Impairment (Quarterly) stood at $966,000 in 2021, then tumbled by 100.31% to -$3,000 in 2022, then spiked by 7,666.67% to $227,000 in 2023, then plummeted by 99.56% to $1,000 in 2024, then spiked by 977.59% to $625,000 in 2025.
  • Its Asset Writedowns and Impairment stands at $625,000 for Q3 2025, versus $267,000 for Q2 2025 and $27,000 for Q1 2025.